859
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Effect of Switching from Telmisartan, Valsartan, Olmesartan, or Losartan to Candesartan on Morning Hypertension

, , , , &
Pages 86-91 | Received 06 Jul 2011, Accepted 11 Aug 2011, Published online: 17 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Di Zhao, Hui Liu & Pingshuan Dong. (2019) A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension. Clinical and Experimental Hypertension 41:1, pages 75-79.
Read now

Articles from other publishers (10)

Kanagasabai Somarathinam, Seshan Gunalan, Ananthasri Sailapathi, Dharani Amirtha Metilda A, Balashanmugam Pannerselvam, M. Mohanasundari, Ashok Kumar Balaraman & Gugan Kothandan. (2023) Antihypertensive effects of pentacyclic triterpenoid from Convolvulus pluricaulis and its plausible mechanism of action hypothesizing its selectivity targeting Mineralocorticoid receptor of RAAS.. Phytomedicine Plus 3:1, pages 100408.
Crossref
Kelli Sims, Winnie Zhu & Kathy Zaiken. (2022) Impact of clinical pharmacy guidance on valsartan recall management: a retrospective review. Drugs & Therapy Perspectives 38:6, pages 278-285.
Crossref
Di Zhao, Hui Liu & Pingshuan Dong. (2018) Antihypertensive effect of azilsartan versus olmesartan in patients with essential hypertension: a meta-analysis. Irish Journal of Medical Science (1971 -) 188:2, pages 481-488.
Crossref
E. V. Sayutina. (2018) Fixed combinations in modern hypertension treatment algorithms. Cardiovascular Therapy and Prevention 17:6, pages 86-94.
Crossref
O. D. OstroumovaA. I. Kochetkov, T. M. OstroumovaE. E. Pavleeva. (2018) Cerebroprotective effects of angiotensin II receptor blockers: candesartan focus. Medical Council:16, pages 14-23.
Crossref
N. A. Dzhaiani. (2017) CANDESARTAN IN CARDIOLOGY PRACTICE. Medical Council:7, pages 12-16.
Crossref
D I Trukhan. (2014) Angiotensin II receptor blockers in the treatment of arterial hypertension in patients with concomitant pathology: focus on candesartan. Systemic Hypertension 11:3, pages 24-29.
Crossref
O D Ostroumova, O V Bondarets & T F Guseva. (2014) The benefits of candesartan usage in the treatment of arterial hypertension. Systemic Hypertension 11:2, pages 62-66.
Crossref
L O Minushkina. (2014) Candesartan in treating hypertension. Systemic Hypertension 11:1, pages 25-29.
Crossref
Dinko Susic, Hassan Fares & Edward D. Frohlich. (2012) Telmisartan Prevents Excess-Salt-Induced Exacerbated (Malignant) Hypertension in Spontaneously Hypertensive Rats. Journal of Cardiovascular Pharmacology and Therapeutics 18:2, pages 126-132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.